Effects of Humoral Immunity and Calreticulin Overexpression on Postoperative Course in Breast Cancer
Authors:
- 17 October 2008
- journal article
- Published by Springer Nature in Pathology and Oncology Research
- Vol. 15 (1) , 89-90
Abstract
The aim was to investigate whether the humoral immunity and overexpression of calreticulin in tumor tissue determined before surgery, correlate with incidence of metastases in breast cancer patients within two years after operation. Before operation, their humoral immunity and overexpression of caleticulin and Her-2/neu in tumor tissue were analyzed by immunohystochemistry. In 23 patients with metastases in regionally lymph nodes, seven had Her-2/neu overexpression. Among those seven patients, three developed distant metastasis (two women one year and in one woman two years after surgery) and all of them showed the presence of stromal IgG immunoreactivity and overexpression of calreticulin in their tumors tissue. Preliminary data showed that serum IgG immunoreactivity to tumor stroma in combination with overexpression of calreticulin in tumor cells correlate with postoperative appearance of metastases, particularly in the group of patients with Her-2/neu overexpressed tumors and metastases in axillary lymph nodes.Keywords
This publication has 9 references indexed in Scilit:
- The Urokinase/Urokinase Receptor System Mediates the IgG Immune Complex-Induced Inflammation in LungThe Journal of Immunology, 2005
- Impaired Cytolytic Activity in Calreticulin-Deficient CTLsThe Journal of Immunology, 2005
- Proteomic profiling for cancer progression: Differential display analysis for the expression of intracellular proteins between regressive and progressive cancer cell linesProteomics, 2005
- Size of Breast Cancer Metastases in Axillary Lymph Nodes: Clinical Relevance of Minimal Lymph Node InvolvementJournal of Clinical Oncology, 2005
- Differential downregulation of endoplasmic reticulum-residing chaperones calnexin and calreticulin in human metastatic melanomaCancer Letters, 2004
- Vascular endothelial growth factor secretion by tumor-infiltrating macrophages essentially supports tumor angiogenesis, and IgG immune complexes potentiate the process.2002
- Humoral immunity to human breast cancer: antigen definition and quantitative analysis of mRNA expression.2001
- Perforin Lytic Activity Is Controlled by CalreticulinThe Journal of Immunology, 2000
- The HER‐2/ neu Oncogene in Breast Cancer: Prognostic Factor, Predictive Factor, and Target for TherapyThe Oncologist, 1998